Metraipolis › archive › dc_424abcfe0f8e
Efficacy of Empagliflozin on Liver Enzymes, Lipid Profile and BMI in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A… — Europe PMC PMID:42504019
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42504019
- DOI
- 10.1002/edm2.70294
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-18T14:10:35.313Z
- SHA-256 of the archived text
c95bfa12c427cde82e46268b53aa88e172748e762f97d3a1157c3e03a2a2dddc- Stable URL of this page
https://metraipolis.com/documento/dc_424abcfe0f8e
How to cite
Efficacy of Empagliflozin on Liver Enzymes, Lipid Profile and BMI in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A… — Europe PMC PMID:42504019 — Europe PMC (en), https://europepmc.org/article/MED/42504019 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_424abcfe0f8e (Metraipolis archive dc_424abcfe0f8e, sha256 c95bfa12c427cde82e46268b53aa88e172748e762f97d3a1157c3e03a2a2dddc)
BibTeX
@misc{dc424abcfe0f8e,
title = {Efficacy of Empagliflozin on Liver Enzymes, Lipid Profile and BMI in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A… — Europe PMC PMID:42504019},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42504019},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_424abcfe0f8e; sha256 c95bfa12c427cde82e46268b53aa88e172748e762f97d3a1157c3e03a2a2dddc},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42504019. Agents can read the archived copy with the MCP tool read_document.